1. [Plasma kallikrein clearance by the liver in experimental cirrhosis].
- Author
-
de Toledo CF, Loureiro-Silva MR, Molina HM, Lanzoni VP, Kouyoumdjian M, and Borges DR
- Subjects
- Age Factors, Analysis of Variance, Animals, Body Weight drug effects, Metabolic Clearance Rate, Organ Size drug effects, Perfusion, Prognosis, Rats, Rats, Wistar, Carbon Tetrachloride administration & dosage, Kallikreins metabolism, Liver metabolism, Liver Cirrhosis, Experimental physiopathology
- Abstract
Aim: To study the hepatic clearance of a glycoprotein (rat plasma kallikrein) by the liver of rats with experimental decompensated cirrhosis., Material and Methods: Cirrhosis was induced by intragastrically administration of carbon tetrachloride 520 mg/kg/week, during 16-19 weeks. After this period, each liver was isolated, exsanguinated and perfused at 37 degrees C with 10nM rat plasma kallikrein (RPK)., Results: 58% of the animals died during the treatment and the remaining developed prostration, ascites, jaundice and bleeding; at the end of the treatment period serum aminotransferases were not altered and serum albumin decreased. The liver histology showed cirrhosis. RPK clearance rate of the cirrhosis group (5.4 +/- 0.9 pmol/g liver/10 min) was significantly lower (p < 0.05) than that of the control group (13.5 +/- 2.7 pmol/g liver/10 min)., Conclusion: The development of cirrhosis is associated with a decreased hepatic clearance of a glycoprotein which endocytosis is mediated by a receptor.
- Published
- 1995